JPRN-UMIN000046366已完成未知
An open label single group study to investigate the effect of granular ceramic treated water with ELCE (R) showerhead on dry skin. - Clinical trial to investigate the effect of granular ceramic treated water with ELCE (R) showerhead on dry skin.
niversity of Miyazaki0 个研究点目标入组 14 人开始时间: 2021年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Subjects who answered in the self-reported health questionnaire that they currently have a skin disease that requires treatment. 2. Subjects who answered in the self-reported health questionnaire that they have had or are currently suffering from respiratory, gastrointestinal, hepatic/gallbladder/pancreatic, hematologic, renal, endocrine, cardiovascular and/or mental disease that requires hospital treatment. 3. Subjects who had a serious injury or surgical history within 12 weeks prior to this study. 4. Heavy smokers (more than 21 cigarettes per day), alcohol addicts (more than 80g per day alcohol), subjects who are alcohol or drug dependence, subjects who are suspected of alcohol or drug dependence. 5. Subjects who are undergoing special facial care (e.g. facial appliances, aesthetic treatments, peels, laser treatments, etc.) which would affect this study. 6. Subjects who are pregnant or lactating, or subjects who expect to be pregnant during this study. 7. Subjects who have cognitive disorder or who have possibility of the disorder. 8. Subjects who participated and took the study drug in other clinical trials within four weeks prior to this study. 9. Subjects who are judges as unsuitable for this study by the principal investigator or subinvestigators.
研究者
相似试验
已完成
不适用
This is a single centre study wherein the safety and efficacy of combination of Pterostilbene, Garcinol,Anthocyanin will be assessed for weight management in adult male and/or female obese or overweight patients.CTRI/2016/07/007089Sami Labs Limited36
进行中（未招募）
1 期
A study to understand disease biology and to test the effect and safety of inhaled nemiralisib in adult patients with APDSEUCTR2015-004876-31-GBGlaxoSmithKline Research & Development Ltd20
招募中
1 期
An open label, single arm study to evaluate single and multiple dose pharmacokinetics, safety and tolerability, and to explore clinical outcomes of treatment with intravenous (IV) zanamivir in neonates and infants under 6 months of age with confirmed complicated influenza infection.CTIS2024-510663-34-00Glaxosmithkline Research & Development Limited12
进行中（未招募）
1 期
An open label, single arm study to evaluate the pharmacokinetics, safety and tolerability of intravenous (IV) zanamivir in hospitalised neonates and infants under 6 months of age with confirmed influenza infectioInfluenzaEUCTR2019-001588-63-NLGlaxoSmithKline Research & Development Limited12
进行中（未招募）
1 期
An open label, single arm study to evaluate the pharmacokinetics, safety and tolerability of intravenous (IV) zanamivir in hospitalised neonates and infants under 6 months of age with confirmed influenza infectioInfluenzaEUCTR2019-001588-63-PLGlaxoSmithKline Research & Development Limited12